BAYER AG SPON ADR REP 1 NPV (BAYRY)

115.11
1.35 1.19
OTC
Prev Close 113.75
Open 114.35
Day Low/High 114.35 / 115.59
52 Wk Low/High 91.53 / 125.20
Volume 46.96K
Exchange OTC
Shares Outstanding 826.95B
Market Cap 83.95B
Div & Yield N.A. (N.A)

Latest News

European Stocks Fall on Earnings Upsets, Politics

European Stocks Fall on Earnings Upsets, Politics

European stocks were weaker and bonds higher as unease returned to markets.

European Markets Fall as More Corporate Earnings Hit

European Markets Fall as More Corporate Earnings Hit

Corporate earnings and resurgent concerns over politics hit European benchmarks on Thursday.

Bayer Offers Further Detail on Financing Monsanto Takeover

Bayer Offers Further Detail on Financing Monsanto Takeover

Bayer isn't expecting their deal for Monsanto to be derailed by regulatory issues, despite recent delays.

Bayer's Cautious 2017 Outlook Causes Stock to Slump

Bayer's Cautious 2017 Outlook Causes Stock to Slump

Bayer shares fell after the drugmaker posted solid full-year earnings but said its crop sciences unit would see modest growth in 2017 as it completes its $66 billion Monsanto takeover.

Global Financial News: Earnings In The Spotlight

Global Financial News: Earnings In The Spotlight

A week full of financial reports continues, as Bayer and Lloyds post full-year earnings

European Stocks Extend Gains as Economic Data Continues to Impress

European Stocks Extend Gains as Economic Data Continues to Impress

European stocks tested multi-month highs Wednesday after better-than-expected business sentiment data from Germany and an upgrade to the fourth quarter pace of growth in the United Kingdom.

Bayer Shares Drop After Cautious 2017 Outlook For Crop Science Unit

Bayer Shares Drop After Cautious 2017 Outlook For Crop Science Unit

Bayer shares fell after the drugmaker posted solid full-year earnings but said its crop sciences unit would see modest growth in 2017 as it completes its $66 billion Monsanto takeover.

Week Ahead: Fed Is Expected to Toe the Party Line

Week Ahead: Fed Is Expected to Toe the Party Line

Investors will be watching a newly hawkish Federal Reserve in the coming week.

Basic Materials Basically Are a Good Place to Be

Basic Materials Basically Are a Good Place to Be

Chemical companies, lumber producers and other sectors that should benefit from capital spending look to do well going forward.

Regeneron Pharmaceuticals Could Be Ready to Rebound

Regeneron Pharmaceuticals Could Be Ready to Rebound

Regeneron has faced a lower stock price and patent wrangling. But the stock could be ready to rise again.

5 Things You Must Know Before the Market Opens Thursday

5 Things You Must Know Before the Market Opens Thursday

U.S. stock futures and shares in London and Asia fall Thursday after Donald Trump offers few details on his policies during his first press conference since winning the U.S. election.

European Pharma Shares Hammered After Trump Press Conference Attack

European Pharma Shares Hammered After Trump Press Conference Attack

European health care and pharmaceutical company shares were hit hard Thursday after President-elect Donald Trump accused some firms of 'getting away with murder' in his Wednesday press conference.

'Stage Is Set' for M&A to Continue in 2017

'Stage Is Set' for M&A to Continue in 2017

Elizabeth Lim, Mergermarket America head research editor, expects further energy consolidation and increased media mergers in 2017.

Analysts Mixed on Health Care Stocks in the New Year

Analysts Mixed on Health Care Stocks in the New Year

While there is deep uncertainty about how politics will affect the health care sector in the new year, analysts seem excited about some opportunities in pharmaceuticals.

European Stocks Mixed, Oil Rises Higher in Holiday-Thinned Trading

European Stocks Mixed, Oil Rises Higher in Holiday-Thinned Trading

European stocks opened a holiday-thinned session with caution as U.S. dollar strength continues to drive sentiment.

European Stock Markets Rise as Investors Buy Back Risk Assets; London Leads

European Stock Markets Rise as Investors Buy Back Risk Assets; London Leads

U.K. stocks are buoyed by retail sales at a 14-year high, prompting a resurgence of consumer and real estate stocks.

European Stocks Slide as Bond Yields, U.S. Dollar Creep Higher

European Stocks Slide as Bond Yields, U.S. Dollar Creep Higher

European stocks are in the red Wednesday as government bond yields edge higher amid the global inflation trade.

Here's Which Pharma Giants Might Want to Buy Pfizer's Consumer Health Unit

Here's Which Pharma Giants Might Want to Buy Pfizer's Consumer Health Unit

A sale or spinoff of this business will likely get the attention of competitors that want to increase their over-the-counter product units.

Roche's Haemophilia Drug Difficulties Has Rivals Looking for an Edge

Roche's Haemophilia Drug Difficulties Has Rivals Looking for an Edge

Pfizer, Bayer, Shire are among rivals bracing for Roche's ACE910.

Will Seed and Farm-Chemical Producers Sow Our Food Needs in Asia?

Will Seed and Farm-Chemical Producers Sow Our Food Needs in Asia?

A WWF report shows how fragile our hold on the world's ecology is. Does Asia represent the future of food production?

It's Not Too Late to Buy Time Warner, Monsanto, Other M&A Targets

It's Not Too Late to Buy Time Warner, Monsanto, Other M&A Targets

Some of the biggest deals already announced on Wall Street are currently pricing in hefty premiums for investors willing to take the risk.

Four Stock Picks for 2017

Four Stock Picks for 2017

Don't sell these shares just yet.

Bayer Beats Estimates as Drugs Gain While Crops Stall

Bayer Beats Estimates as Drugs Gain While Crops Stall

Strong drug sales allow the German group to increase its full-year earnings forecast, while wilting crop science revenue pose more questions about the wisdom of buying Monsanto.

European Stocks Slide As Oil Falls Back and Earnings Disappoint

European Stocks Slide As Oil Falls Back and Earnings Disappoint

U.K. lender Lloyds falls after a third-quarter profit miss, while luxury goods maker Kering surges.

Cramer: Regulators Are Looking to Kill, Not Bless Mega Mergers

Cramer: Regulators Are Looking to Kill, Not Bless Mega Mergers

This is new doctrine having to do with innovation and the stifling of innovation to create new products.

Syngenta Warns of Delay in $43 Billion Takeover by ChemChina

Syngenta Warns of Delay in $43 Billion Takeover by ChemChina

The Swiss fertilizers maker says regulators in the EU and elsewhere have demanded more information.

Don't Succumb to the Buzz of the Mega Merger

Don't Succumb to the Buzz of the Mega Merger

Results have shown that many major "blockbuster" deals aren't blockbuster investments later.

Cramer: Don't Buy Either AT&T or Time Warner on Merger News

Cramer: Don't Buy Either AT&T or Time Warner on Merger News

Regulatory issues will weigh on this deal, because of populist politics.